Department of Dermatology, Venerology and Allergology CCM/CBF

Projects

• Functional Food
• A clinical trial to assess the safety and efficacy of Dysport to improve the appearance of glabellar lines.
• A Study to Compare the Safety and Efficacy of Botulinum Type A Toxin for the Treatment of Glabellar Lines.
• Acne Dose Range
• Acne Dose Range
• AGA Frontal Foam
• Aktivierung allergenspezifischer T-Zellen während der spezifischen Immuntherapie
• Anaphylaxie-Sentinel
• Antioxidants EFRE
• Arsentrioxid bei CTCL
• Arzneimittelreaktionen an der Haut
• Beobachtungsstudie: Muckle-Wells-Syndrom
• Bimatoprost Men
• Bimatoprost Women
• Bio-Nano-Responses: Nanoparticles Containing Selective Probes (NANO-SELECT)
• Birch Associated Soy Allergy and Immuno-Therapy
• BRF113929 bei Melanom
• Clinical trial of ATX-101 versus placebo for the reduction of localized subcutaneous fat in the submental area
• Cold Urticaria
• COST Action BM1007 "Mast Cells and Basophils – Targets for Innovative Therapies"
• Cutaneous and Mucosal HIV Vaccination
• Determination of cutaneous radical scavenging activity before and after the intake of curly kale extract
• Development of a DNA vaccine for visceral leishmaniasis
• Development of a preventive supporting therapy skin care product for barrier disrupted skin.
• Embody I
• Entwicklung von Präventionsstrategien gegen Hautnebenwirkungen bei der Chemotherapie
• European Centre for Allergy Research Foundation (ECARF)
• European evidence based (S3) - Guidelines for the treatment of acne
• European S3-Guidelines on the systemic treatment of psoriasis vulgaris
• Evidenzbericht zur S3-Leitlinie Diagnostik und Therapie des Mundhöhlenkarzinoms
• Follicular Targeting - Development of particle-based strategies for the treatment of hair and skin disorders
• Global Allergy and Asthma European Network (GA²LEN NoE)
• Global management of facial rejuvenation with hyaluronic acid dermal fillers
• GT-08-Phleumpratense Grastabletten bei R
• IgE and antibody profiling
• IgE and Immunmodulators
• Immunmodulation of type-I allergy via nuclear hormone receptor ligands.
• Immunological changes in psoriasis patients
• Immunsuppression
• Impfprävention HPV-assoziierter Neoplasien
• Langzeittherapie der Psoriasis vulgaris mit Infliximab.
• LC-PUFA in allergy mouse-models
• Lizenzeinnahmen
• Mast cell-driven down regulation of chronic inflammation
• MC Therapy
• Merz-HIV-Studie MRZ 90030/VA/6001
• MINALO3004
• MINALO3005
• Moderate-to-severe psoriasis: a systematic review and meta-analysis of long-term treatment
• Movida – Identifizierung und funktionelle Bedeutung von Vitamin-D-Polymorphismen
• Nappy Skin
• PeTrA-TV: Therapeutische Vakzinierung
• PlasmaMed 2
• Predictive value of biomarkers for the assessment of digital ulcers in systemic sclerosis
• Prognosis factors of venom allergy
• Proof of concept clinical studies for hair and skin science
• Rosacea Biopsien
• Sensitization of melanoma cells for death ligand-mediated apoptosis
• Sensitization of melanoma cells for death ligand-mediated apoptosis
• Study of CD07743 for the improvement of Lateral Canthal Lines (crow’s feet)
• Study of Evenor Deep versus Perlane in the treatment of soft tissue contour deformities
• Study of MDF-100 after bilateral dermal implantation for correction of moderate to severe facial wrinkles and folds
• Study to Evaluate the Safety and Efficacy of Botulinum Toxin Type A in Subjects with Facial Rhytides
• Synthetic Polymer Libraries
• S2k - Guideline on the Therapy of Acne
• Ticilimumab bei Melanom
• TNF as a regulator in the skin
• Topische Vakzinierung mit funktionalen Nanopartikeln
• Trial to assess the efficacy and safety of Vagantin® in the treatment of focal palmar-axillary hyperhidrosis
• Tumor diagnostic in dermatology using multiphoton tomography and CARS
• VEGAL: Allergenicity of food allergens
• Vergleich zum Nachweis der Wirksamkeit von 2 Botulinumtoxinen Typ A bei moderaten bis schweren Stirnfalten
• VW-Stiftung
• Zalain-Nagelpflaster

If the list does not contain any entry, the request was executed without results.